B. Rambeck

3.2k total citations
56 papers, 1.7k citations indexed

About

B. Rambeck is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, B. Rambeck has authored 56 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Psychiatry and Mental health, 47 papers in Pediatrics, Perinatology and Child Health and 16 papers in Oncology. Recurrent topics in B. Rambeck's work include Epilepsy research and treatment (53 papers), Pharmacological Effects and Toxicity Studies (47 papers) and Drug Transport and Resistance Mechanisms (16 papers). B. Rambeck is often cited by papers focused on Epilepsy research and treatment (53 papers), Pharmacological Effects and Toxicity Studies (47 papers) and Drug Transport and Resistance Mechanisms (16 papers). B. Rambeck collaborates with scholars based in Germany, United States and Netherlands. B. Rambeck's co-authors include Theodor W. May, Uwe Jürgens, Peter Wolf, Elisabeth Korn‐Merker, Ralf Schnabel, Wolfgang Löscher, Ulrich Specht, Andrea Tipold, Christian Brandt and Alois Ebner and has published in prestigious journals such as Pharmaceutical Research, Epilepsia and Clinical Pharmacokinetics.

In The Last Decade

B. Rambeck

54 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Rambeck Germany 21 1.3k 1.3k 425 282 219 56 1.7k
Barry E. Gidal United States 29 1.7k 1.3× 1.6k 1.2× 379 0.9× 397 1.4× 249 1.1× 68 2.4k
Alan Richens United Kingdom 22 1.2k 0.9× 1.1k 0.9× 180 0.4× 387 1.4× 224 1.0× 58 2.0k
Patrick N. Friel United States 23 858 0.7× 825 0.7× 153 0.4× 238 0.8× 136 0.6× 46 1.4k
Dennis R. Doose United States 20 856 0.7× 937 0.7× 184 0.4× 213 0.8× 154 0.7× 27 1.3k
M. J. Eadie Australia 23 974 0.7× 716 0.6× 174 0.4× 126 0.4× 162 0.7× 88 1.7k
Willi Cawello Germany 23 549 0.4× 612 0.5× 226 0.5× 199 0.7× 232 1.1× 75 1.4k
Eiji Yukawa Japan 22 683 0.5× 500 0.4× 314 0.7× 59 0.2× 248 1.1× 99 1.6k
R H Lévy United States 19 674 0.5× 464 0.4× 328 0.8× 110 0.4× 138 0.6× 33 1.3k
Cinzia Fattore Italy 17 731 0.6× 772 0.6× 118 0.3× 230 0.8× 117 0.5× 28 1.1k
Eppo van der Kleijn Netherlands 24 455 0.3× 383 0.3× 170 0.4× 234 0.8× 274 1.3× 66 1.5k

Countries citing papers authored by B. Rambeck

Since Specialization
Citations

This map shows the geographic impact of B. Rambeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Rambeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Rambeck more than expected).

Fields of papers citing papers by B. Rambeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Rambeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Rambeck. The network helps show where B. Rambeck may publish in the future.

Co-authorship network of co-authors of B. Rambeck

This figure shows the co-authorship network connecting the top 25 collaborators of B. Rambeck. A scholar is included among the top collaborators of B. Rambeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Rambeck. B. Rambeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schaefer, Marion, et al.. (2011). Fluctuation of lacosamide serum concentrations during the day and occurrence of adverse drug reactions – First clinical experience. Epilepsy Research. 95(3). 207–212. 19 indexed citations
2.
Luna‐Tortós, Carlos, B. Rambeck, Uwe Jürgens, & Wolfgang Löscher. (2009). The Antiepileptic Drug Topiramate is a Substrate for Human P-glycoprotein but Not Multidrug Resistance Proteins. Pharmaceutical Research. 26(11). 2464–2470. 40 indexed citations
3.
May, Theodor W., et al.. (2009). Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients. Acta Neurologica Scandinavica. 93(6). 393–397. 3 indexed citations
4.
5.
May, Theodor W., et al.. (2007). Serum Concentrations of Pregabalin in Patients With Epilepsy: The Influence of Dose, Age, and Comedication. Therapeutic Drug Monitoring. 29(6). 789–794. 36 indexed citations
6.
Gorji, Ali, B. Rambeck, Uwe Jürgens, et al.. (2006). Neocortical Microenvironment in Patients with Intractable Epilepsy: Potassium and Chloride Concentrations. Epilepsia. 47(2). 297–310. 16 indexed citations
7.
Fröscher, W., Markus Hoffmann, Andreas Meyer, et al.. (2005). Topiramate: a prospective study on the relationship between concentration, dosage and adverse events in epileptic patients on combination therapy. Epileptic Disorders. 7(3). 237–248. 30 indexed citations
8.
May, Theodor W., Uwe Jürgens, B. Rambeck, & Ralf Schnabel. (1999). Comparison between premortem and postmortem serum concentrations of phenobarbital, phenytoin, carbamazepine and its 10,11-epoxide metabolite in institutionalized patients with epilepsy. Epilepsy Research. 33(1). 57–65. 20 indexed citations
9.
Rambeck, W. A., et al.. (1996). Urinary pyridinium crosslinks as markers of bone resorption in osteoporosis. Osteoporosis International. 6(S1). 275–275.
10.
11.
Korn‐Merker, Elisabeth, et al.. (1994). Pharmacokinetics of Sulthiame in Epileptic Patients. Therapeutic Drug Monitoring. 16(3). 251–257. 16 indexed citations
12.
13.
Rambeck, B. & Peter Wolf. (1993). Lamotrigine Clinical Pharmacokinetics. Clinical Pharmacokinetics. 25(6). 433–443. 192 indexed citations
14.
Rambeck, B., et al.. (1992). Postmortem Concentrations of Phenytoin in Different Regions of the Brain and in the Serum. Therapeutic Drug Monitoring. 14(1). 27–35. 14 indexed citations
15.
Rambeck, B., et al.. (1990). Valproic Acid-Induced Carbamazepine-10,11-Epoxide Toxicity in Children and Adolescents. European Neurology. 30(2). 79–83. 33 indexed citations
16.
Rambeck, B., et al.. (1990). Postmortem Serum Protein Binding and Brain Concentrations of Antiepileptic Drugs in Autoptic Specimens from 45 Epileptic Patients. Therapeutic Drug Monitoring. 12(6). 533–540. 16 indexed citations
17.
Rambeck, B., et al.. (1984). Urinary Hydroxyphenytoin/Creatinine Ratios as an Index of Compliance in Adult Epileptic Patients on Phenytoin Therapy. Therapeutic Drug Monitoring. 6(2). 164–172. 1 indexed citations
18.
Rambeck, B., et al.. (1981). Quantitative Simultaneous Determination of Eight Common Antiepileptic Drugs and Metabolites by Liquid Chromatography. Therapeutic Drug Monitoring. 3(4). 397–414. 13 indexed citations
19.
Rambeck, B., et al.. (1981). Systematic Method of Development in Liquid Chromatography Applied to the Determination of Antiepileptic Drugs. Therapeutic Drug Monitoring. 3(4). 377–396. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barry E. Gidal Breakdown of academic impact, for papers by Alan Richens Breakdown of academic impact, for papers by Patrick N. Friel Breakdown of academic impact, for papers by Dennis R. Doose Breakdown of academic impact, for papers by M. J. Eadie Breakdown of academic impact, for papers by Willi Cawello Breakdown of academic impact, for papers by Eiji Yukawa Breakdown of academic impact, for papers by R H Lévy Breakdown of academic impact, for papers by Cinzia Fattore Breakdown of academic impact, for papers by Eppo van der Kleijn
Rankless by CCL
2026